Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07635485
What this trial is testing

VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML

Who this might be right for
Hypoplastic Acute Myeloid LeukemiaSecondary AML (Adult)
The First Affiliated Hospital of Soochow University 50
Testing effectiveness (Phase 2)UnknownNCT04958538
What this trial is testing

MTX and Steroid for III-IV aGVHD Treatment

Who this might be right for
Acute Graft Versus Host Disease
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01280955
What this trial is testing

Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant

Who this might be right for
Failure of Bone Marrow Graft
Mitchell Horwitz, MD 41
Early research (Phase 1)WithdrawnNCT03939585
What this trial is testing

Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT

Who this might be right for
Allogeneic Stem Cell Transplant CandidateAcute Myeloid/Lymphoblastic LeukemiaMyelodysplastic Syndrome+2 more
Leland Metheny
Testing effectiveness (Phase 2)Study completedNCT00027547
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Not applicableUnknownNCT05087784
What this trial is testing

AlloLife - Life After Transplantation

Who this might be right for
SurvivorshipStem Cell Transplant Complications
University Hospital, Essen 192
Testing effectiveness (Phase 2)Ended earlyNCT00523809
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor

Who this might be right for
Breast CancerOvarian Cancer
M.D. Anderson Cancer Center 5
Early research (Phase 1)Active Not RecruitingNCT04980404
What this trial is testing

Inqovi Maintenance Therapy in Myeloid Neoplasms

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaStem Cell Leukemia
Massachusetts General Hospital 22
Testing effectiveness (Phase 2)Study completedNCT02641236
What this trial is testing

Gut Decontamination In Pediatric Allogeneic Hematopoietic

Who this might be right for
Hematopoietic Stem Cell Transplantation (HSCT)Acute GVH Disease
Dana-Farber Cancer Institute 24
Not applicableStudy completedNCT00888316
What this trial is testing

Iron Overload in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
CancerHematopoietic Stem Cell TransplantationAllogeneic Hematopoietic Cell Transplantation
Masonic Cancer Center, University of Minnesota 112
Testing effectiveness (Phase 2)Study completedNCT02294552
What this trial is testing

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaLymphoma+3 more
Ivan S Moiseev 200
Early research (Phase 1)Study completedNCT02917096
What this trial is testing

Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisSecondary Myelofibrosis
City of Hope Medical Center 18
Not applicableUnknownNCT03294824
What this trial is testing

Non Randomized Comparative Study With Control

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 90
Early research (Phase 1)WithdrawnNCT02548468
What this trial is testing

Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma

Who this might be right for
Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides and Sezary SyndromeStage IIB Mycosis Fungoides and Sezary Syndrome+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Early research (Phase 1)Looking for participantsNCT06934382
What this trial is testing

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Stephan Grupp MD PhD 33
Early research (Phase 1)Study completedNCT03207191
What this trial is testing

Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia (AML) Relapse
Philogen S.p.A. 15
Not applicableStudy completedNCT03377010
What this trial is testing

UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in HSCT Survivors

Who this might be right for
Hematopoietic Neoplasm
University of Florida 103
Not applicableNot Yet RecruitingNCT07581093
What this trial is testing

The REACT Study: REhabilitation and ACTivity in Allogenic Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)
University of Dublin, Trinity College 140
Early research (Phase 1)UnknownNCT05089838
What this trial is testing

CMV-TCR-T Cells for Refractory CMV Infection After HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationCMV Infection
Xiao-Jun Huang 12
Large-scale testing (Phase 3)UnknownNCT03256071
What this trial is testing

Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Hematopoietic Stem Cell TransplantationConditioning
The First Affiliated Hospital of Soochow University 90
Next Page